1. Home
  2. CCSI vs MDXG Comparison

CCSI vs MDXG Comparison

Compare CCSI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$34.85

Market Cap

493.6M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.69

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
MDXG
Founded
2021
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.6M
530.2M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
CCSI
MDXG
Price
$34.85
$3.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$37.50
$9.00
AVG Volume (30 Days)
152.9K
1.1M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
1.30
N/A
Revenue
$349,696,000.00
$418,630,000.00
Revenue This Year
$3.33
N/A
Revenue Next Year
$2.70
$13.02
P/E Ratio
$26.66
N/A
Revenue Growth
N/A
19.99
52 Week Low
$19.42
$3.03
52 Week High
$37.30
$7.99

Technical Indicators

Market Signals
Indicator
CCSI
MDXG
Relative Strength Index (RSI) 64.62 52.64
Support Level $25.76 $3.47
Resistance Level $36.73 $3.84
Average True Range (ATR) 1.84 0.13
MACD 0.01 0.01
Stochastic Oscillator 78.60 56.25

Price Performance

Historical Comparison
CCSI
MDXG

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: